Adrien Reymond is managing director of PETNET Solutions’ Lab in Lisses (Paris area). A graduate from Ecole Polytechnique de Montréal (Canada), M. Reymond also holds a degree in Industrial Pharmacology (Université Claude Bernard Lyon 1, France).
He started his career in radiopharmaceutics in 2007, as a quality control manager, and joined PETNET in 2010.
PETNET Solutions Inc., a wholly owned subsidiary of Siemens Medical Solutions USA, Inc., operates the world's largest network of PET radiopharmacies, with over 50 locations worldwide.
Des avancées technologiques significatives, des applications de plus en plus nombreuses, la médecine nucléaire est en plein boom. Sortie des labos il y a quelques années seulement, c'est désormais une industrie en plein essor. Le directeur d'un site industriel nous raconte.
Significant tech breakthroughs, a growing number of applications, mature industrial processes: in recent years many factors have boosted the development of nuclear medicine. Not so long ago, it was a matter of R&D. Now it's an industry. One of its most interesting business lines is the production of FDG, the most widely used radioactive tracer in nuclear medical imaging.